hNIS protein in thyroid: The iodine supply influences its expression and localization

Thyroid

Volumn 17, Issue 7, 2007, Pages 613-618

  Scipioni, Angela ^a   Ferretti, Elisabetta ^a   Soda, Giuseppe ^a   Tosi, Emanuele ^a   Bruno, Rocco ^b   Costante, Giuseppe ^c   Meringolo, Domenico ^d   Arturi, Franco ^c   Durante, Cosimo ^a   Amorosi, Andrea ^c   Foschini, Maria Pia ^e   Nardi, Francesco ^a   Russo, Diego ^c   Filetti, Sebastiano ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Tinchi Pisticci Hospital   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d Ospedale di Bentivoglio   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; LIOTHYRONINE; SODIUM IODIDE SYMPORTER; THYROXINE; TUBULIN;

ADULT; AGED; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GOITER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IODINE DEFICIENCY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STATISTICAL ANALYSIS; THYROID FUNCTION TEST; THYROID NODULE; URINARY EXCRETION;

ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION; GOITER; HUMANS; IODIDES; IODINE; MALE; MIDDLE AGED; SYMPORTERS; THYROID GLAND; THYROID HORMONES; THYROID NODULE;

EID: 34548184863     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0064     Document Type: Article

References (15)

1. Krohn K, Fuhrer D, Bayer Y, Eszlinger M, Brauer V, Neumann S, Paschke R 2005 Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev 26:504-524.
2. Aghini-Lombardi F, Antonangeli L, Martino E, Vitti P, Maccherini D, Leoli F, Rago T, Grasso L, Valeriano R, Balestrieri A, Pinchera A 1999 The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab 84:561-566.
3. Rojeski MT, Gharib H 1985 Nodular thyroid disease. Evaluation and management. New Engl J Med 313:428-436.
4. Demeester-Mirkine N, Van Sande J, Corvilain J, Dumont JE 1975 Benign thyroid nodule with normal iodide trap and defective organification. J Clin Endocrinol Metab 41:1169-1171.
5. Rosaj J, Carcangiu ML, De Lellis RA 1992 Atlas of tumor pathology. In: Tumors of the Thyroid Gland. Third series. Armed Forced Institute of Pathology, Washington DC, pp 21-47.
6. Thilly CH, Vanderpas JB, Bebe N, Ntambue K, Contempre B, Swervnen B, Moreno-Reyes R, Bourdoux P, Delange F 1992 Iodine deficiency, other trace elements, and goitrogenic factors in the etiopathogeny of iodine deficiency disorders (IDD). Biol Trace Element Res 32:229-243.
7. Filetti S, Bidart JM, Arturi F, Caillou B, Russo D, Schlumberger M 1999 Sodium/iodide symporter (hNIS): a key transport system in thyroid cancer cell metabolism. Eur J Endocrinol 141:443-457.
8. Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N 2003 The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 24:48-77.
9. Costante G, Grasso L, Schifino E, Marasco MF, Crocetti U, Capula C, Chiarella R, Ludovico O, Nocera M, Parlato G, Filetti S 2002 Iodine deficiency in Calabria: characterization of endemic goiter and analysis of different indicators of iodine status region-wide. J Endocrinol Invest 25:201-207.
10. - symporter distribution in human thyroid tissues: an immunohistochemical study. J Clin Endocrinol Metab 83:4102-4106.
11. Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, Regalbuto C, Vigneri R 1992 Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med Sci 93:363-369.
12. Tonacchera M, Viacava P, Fanelli G, Agretti P, De Marco G, De Servi M, Di Cosmo C, Chiovato L, Pinchera A, Vitti P 2004 The sodium-iodide symporter protein is always present at a low expression and confined to the cell membrane in nonfunctioning nonadenomatous nodules of toxic nodular goitre. Clin Endocrinol 61:40-45.
13. Eng PH, Cardona GR, Previti MC, Chin WW, Braverman LE 2001 Regulation of the sodium iodide symporter by iodide in FRTL-5 cells. Eur J Endocrinol 144:139-144.
14. - symporter mRNAs in dog thyroid. Mol Cell Endocrinol 131:195-203.
15. Tonnacchera M, Viacava P, Agretti P, de Marco G, Perri A, di Cosmo C, de Servi M, Miccoli P, Lippi F, Naccarato AG, Pinchera A, Chiovato L, Vitti P 2002 Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein. J Clin Endocrinol Metab 87: 352-357.